<p>, /PRNewswire/ -- Kuehn Law, PLLC，一家股東訴訟律師事務所，正在調查 <strong>DexCom, Inc. (NASDAQ: DXCM)</strong> 的某些高管和董事是否違反了對股東的信託責任。</p>
<p>根據一項聯邦證券訴訟，DexCom 內部人士導致公司對 2024 財年的預期收入進行了錯誤陳述或未能披露重要信息。2024 年 7 月 25 日，Dexcom 公佈了 2024 財年第二季度的財務業績，並下調了 2024 財年全年的收入指引。公司將其業績和下調指引歸因於其執行的 “幾項關鍵戰略舉措”，這些舉措 “未能達到他們的高標準”。在這一消息發佈後，DexCom 的股價跌至 64.00 美元，下降約 40.66%。</p>
<p>如果您目前持有 DXCM <strong>並在 2023 年 4 月 28 日之前購買</strong>，請通過電子郵件聯繫 Justin Kuehn, Esq.，郵箱為 [email protected]，或撥打 (833) 672-0814。<strong>Kuehn Law 承擔所有案件費用，並不向投資者客户收費。</strong> <em>股東應立即聯繫該事務所，因為您可能有有限的時間來維護您的權利。</em></p>
<p><strong>您參與的重要性：</strong></p>
<p>作為股東，您的聲音很重要，通過參與，您為金融市場的誠信和公平做出貢獻。<em>您的投資。您的聲音。您的未來。</em> ™</p>
<p>有關更多信息，請訪問股東衍生訴訟 - Kuehn Law。</p>
<p>律師廣告。以往的結果並不保證類似的結果。</p>
<p>聯繫方式：</p>
<p>Kuehn Law, PLLC</p>
<p>Justin Kuehn, Esq.</p>
<p>53 Hill Street, Suite 605</p>
<p>Southampton, NY 11968</p>
<p>[email protected]</p>
<p>(833) 672-0814</p>
<p>來源 Kuehn Law, PLLC</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTE5Jk5ld3NJdGVtSWQ9Tlk3NzkwOCZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MTkxNDA3UFJfTkVXU19VU1BSX19fX19OWTc3OTA4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTE5Jk5ld3NJdGVtSWQ9Tlk3NzkwOCZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MTkxNDA3UFJfTkVXU19VU1BSX19fX19OWTc3OTA4"/></p>

德康醫療

<p>Kuehn Law, PLLC 正在調查 DexCom, Inc.（納斯達克代碼：DXCM）高管和董事可能違反信託責任的情況，此次調查是基於一起聯邦證券訴訟。訴訟聲稱 DexCom 內部人士對 2024 財年的收入預期進行了虛假陳述，導致公司下調收入指引後，股價大幅下跌約 40.66%。鼓勵在 2023 年 4 月 28 日之前購買 DXCM 的股東聯繫 Kuehn Law 以尋求潛在的法律行動，因為該公司將承擔所有案件費用</p>

<p>, /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of <strong>DexCom, Inc. (NASDAQ: DXCM)</strong> breached their fiduciary duties to shareholders.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Kuehn Law, PLLC，一家股東訴訟律師事務所，正在調查 <strong>DexCom, Inc. (NASDAQ: DXCM)</strong> 的某些高管和董事是否違反了對股東的信託責任。</p>
</div><p>According to a federal securities lawsuit, DexCom insiders caused the company to misrepresent or fail to disclose material information concerning expected revenue for the fiscal year 2024. On July 25, 2024, Dexcom announced its financial results for the second quarter of fiscal 2024 and reduced its revenue guidance for the full fiscal year 2024. The Company attributed its results and lowered guidance on their execution of &#34;several key strategic initiatives&#34; which &#34;did not meet [their] high standards.&#34; On this news, DexCom's stock price fell to $64.00, a decline of about 40.66%.</p>
<div class="lb-trans"><p>根據一項聯邦證券訴訟，DexCom 內部人士導致公司對 2024 財年的預期收入進行了錯誤陳述或未能披露重要信息。2024 年 7 月 25 日，Dexcom 公佈了 2024 財年第二季度的財務業績，並下調了 2024 財年全年的收入指引。公司將其業績和下調指引歸因於其執行的 “幾項關鍵戰略舉措”，這些舉措 “未能達到他們的高標準”。在這一消息發佈後，DexCom 的股價跌至 64.00 美元，下降約 40.66%。</p>
</div><p>If you currently own DXCM <strong>and purchased prior to April 28, 2023</strong> please contact Justin Kuehn, Esq. here, by email at [email protected] or call (833) 672-0814. <strong>Kuehn Law pays all case costs and does not charge its investor clients.</strong> <em>Shareholders should contact the firm immediately as there may be limited time to enforce your rights.</em></p>
<div class="lb-trans"><p>如果您目前持有 DXCM <strong>並在 2023 年 4 月 28 日之前購買</strong>，請通過電子郵件聯繫 Justin Kuehn, Esq.，郵箱為 [email protected]，或撥打 (833) 672-0814。<strong>Kuehn Law 承擔所有案件費用，並不向投資者客户收費。</strong> <em>股東應立即聯繫該事務所，因為您可能有有限的時間來維護您的權利。</em></p>
</div><p><strong>Why Your Participation Matters:</strong></p>
<div class="lb-trans"><p><strong>您參與的重要性：</strong></p>
</div><p>As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. <em>Your investment. Your voice. Your future.</em> ™</p>
<div class="lb-trans"><p>作為股東，您的聲音很重要，通過參與，您為金融市場的誠信和公平做出貢獻。<em>您的投資。您的聲音。您的未來。</em> ™</p>
</div><p>For additional information, please visit Shareholder Derivative Litigation - Kuehn Law.</p>
<div class="lb-trans"><p>有關更多信息，請訪問股東衍生訴訟 - Kuehn Law。</p>
</div><p>Attorney advertising. Prior results do not guarantee similar outcomes.</p>
<div class="lb-trans"><p>律師廣告。以往的結果並不保證類似的結果。</p>
</div><p>Contacts:</p>
<div class="lb-trans"><p>聯繫方式：</p>
</div><p>Kuehn Law, PLLC</p>
<div class="lb-trans"><p>Kuehn Law, PLLC</p>
</div><p>Justin Kuehn, Esq.</p>
<div class="lb-trans"><p>Justin Kuehn, Esq.</p>
</div><p>53 Hill Street, Suite 605</p>
<div class="lb-trans"><p>53 Hill Street, Suite 605</p>
</div><p>Southampton, NY 11968</p>
<div class="lb-trans"><p>Southampton, NY 11968</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>(833) 672-0814</p>
<div class="lb-trans"><p>(833) 672-0814</p>
</div><p>SOURCE Kuehn Law, PLLC</p>
<div class="lb-trans"><p>來源 Kuehn Law, PLLC</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTE5Jk5ld3NJdGVtSWQ9Tlk3NzkwOCZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MTkxNDA3UFJfTkVXU19VU1BSX19fX19OWTc3OTA4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY77908&amp;Transmission_Id=202509191407PR_NEWS_USPR_____NY77908&amp;DateId=20250919"/></p>

Kuehn Law 鼓勵 DexCom, Inc. 的投資者聯繫律師事務所